Cognitive and Performance Enhancing Medication Use to Improve Performance in Poker
Use of neuroenhancers has been studied in groups ranging from students to surgeons; however, use of cognitive and performance enhancing medications (CPEMs) to improve performance in poker has remained largely overlooked. To assess the use of CPEMs to improve poker performance, a survey of poker players was conducted. Participants were recruited via Internet poker forums; 198 completed the online survey. Approximately 28 % of respondents used prescription CPEMs, with the most commonly used including: amphetamine/dextroamphetamine (62 %), benzodiazepines (20 %), and methylphenidate (20 %). CPEMs were used in poker to focus (73 %), calm nerves (11 %), and stay awake (11 %). Caffeine (71 %), as well as conventionally counter-intuitive substances like marijuana (35 %) and alcohol (30 %) were also reported to enhance poker performance. Non-users of CPEMs were dissuaded from use due to not knowing where to get them (29 %), apprehension about trying them (26 %), and legal or ethical concerns (16 %). Respondents most frequently acquired CPEMs via friends/fellow poker players (52 %), or prescription from physician (38 %). Additionally, greater use of CPEMs was associated with living outside the United States (p = 0.042), prior use of prescription medications for improving non-poker related performance (p < 0.001), and amateur and semi-professional player status (p = 0.035). Unmonitored use of pharmacologically active agents and their methods of acquisition highlight safety concerns in this cohort of poker players, especially among non-professional players. The current state of guidance from national organizations on CPEM use in healthy individuals could impact prescribing patterns.
KeywordsCognition Gambling Medications Neuroenhancer Poker
Conflict of interest
The authors declare they have no conflict of interest. No financial support was received for this study.
- British Medical Association. (2007). Boosting your brainpower: Ethical aspects of cognitive enhancements. A discussion paper from the British Medical Association.Google Scholar
- European Alliance for Access to Safe Medicines (2008). The counterfeiting superhighway. Retrieved July 28, 2015, from http://asop.eu/cache/downloads/dqqt3sge9hwssgcgcos440g40/CS%20for%20ASOP%20website.pdf.
- Matusow, M., Calistri, A., & Lavalli, T. (2009). Check-raising the devil. Las Vegas: Cardoza Publishing.Google Scholar
- Poker Static (2010). Mad Poker: Episode 1. Retrieved July 28, 2015 from http://www.pokerstatic.com/mad-poker/episode1/.
- Talbot, M. (2009). Brain gain: The underground world of “neuroenhancing” drugs. New Yorker, 27, 32–43.Google Scholar